Skip to main content
logo
Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.160
+0.030 (2.65%)
At close: Apr 2, 2026, 4:00 PM EDT
1.140
-0.020 (-1.72%)
After-hours: Apr 2, 2026, 6:49 PM EDT

Allarity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
191793378
Market Cap Growth
320.74%103.26%163.38%9.54%-96.22%-
Enterprise Value
5.372.68-10.994.828.6760.78
Last Close Price
1.161.081.17330.66246792.008714580.00
PE Ratio
--1.38-0.07-0.05-0.01-2.48
PS Ratio
58.2954.27----
PB Ratio
1.901.770.72-0.72-26.214.32
P/TBV Ratio
1.691.580.16-0.25-1237.60145.38
P/FCF Ratio
--1.17-0.48-0.25-0.18-5.27
P/OCF Ratio
--1.17-0.49-0.25-0.18-5.27
EV/Sales Ratio
16.778.38----
EV/EBITDA Ratio
--0.210.40-0.28-0.25-2.30
EV/EBIT Ratio
--0.210.40-0.28-0.25-2.29
EV/FCF Ratio
--0.180.62-0.38-0.51-4.08
Debt / Equity Ratio
-0000.960.05
Debt / EBITDA Ratio
-0.11-0.11-0.05-0.08-0.11-0.04
Debt / FCF Ratio
-0.09-0.09-0.08-0.10-0.22-0.07
Net Debt / Equity Ratio
-1.35-1.35-1.54-0.25-15.10-1.04
Net Debt / EBITDA Ratio
1.031.050.67-0.07-0.050.71
Net Debt / FCF Ratio
0.900.901.03-0.09-0.101.26
Asset Turnover
0.020.020000
Quick Ratio
1.841.842.000.070.251.00
Current Ratio
2.132.132.060.140.441.03
Return on Equity (ROE)
-103.80%-103.80%-541.17%-2084.24%-137.78%-121.53%
Return on Assets (ROA)
-63.19%-61.63%-160.28%-128.82%-98.11%-63.64%
Return on Invested Capital (ROIC)
262.97%256.46%1240.54%-545.94%-254.92%-108.68%
Return on Capital Employed (ROCE)
-119.46%-116.50%-573.13%-3368.53%-213.82%-93.53%
Earnings Yield
-60.21%-72.22%-1337.61%-1824.02%-15041.61%-40.39%
FCF Yield
-79.49%-85.38%-206.57%-392.87%-568.46%-18.98%
Buyback Yield / Dilution
-794.77%-794.78%-47373.83%-497.35%-87.14%-7691.04%
Total Shareholder Return
-794.77%-794.78%-47373.83%-497.35%-87.14%-7691.04%
Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q